BSE filing, NSE: MIDINDIA. Summary written from the filing by ALFA Finder's alert engine.
Mid India Industries Ltd: key numbers
- Share price
- ₹6.16
- Market cap
- ₹10.04 Cr
- Revenue (annual)
- ₹13.12 Cr
- Net profit (annual)
- ₹0.30 Cr
- P/E (TTM)
- 58.5×Sector 49.5×
- Promoter holding
- 50.71%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mid India Industries Ltd
All →Mid India Industries Other Announcement
Mid India Industries Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Mid India Industries Annual General Meeting
Mid India Industries held its 35th Annual General Meeting on September 28, 2026, transacting ordinary business including adoption of financial statements and re-appointment of statutory auditors.
Mid India Industries Promoter Buying (Off-Market)
Promoter Pradeep Ganediwal acquired 8.56 lakh shares of Mid India Industries Ltd via off-market inter-se transmission. This transaction increases the promoter's stake by 5.25%.
- Promoter stake change
- +5.25%
Mid India Industries Other Announcement
Mid India Industries Limited informed shareholders that those without registered email addresses will receive a letter providing access to the Annual Report and 35th AGM notice.
Mid India Industries Annual Report
Mid India Industries Limited has submitted its Integrated Annual Report for the financial year 2025-26. The company convened its 35th Annual General Meeting for September 28, 2026.
Mid India Industries Annual General Meeting
Mid India Industries Limited has convened its 35th Annual General Meeting for September 28, 2026. Key agenda items include adopting audited financial statements and re-appointing statutory auditors.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.